Acorda Therapeutics, Inc. Debt to Equity Ratio 2010-2024 | ACORQ
Current and historical debt to equity ratio values for Acorda Therapeutics, Inc. (ACORQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Acorda Therapeutics, Inc. debt/equity for the three months ending March 31, 2024 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $0.27B | $-0.19B | -1.44 |
| 2023-12-31 | $0.27B | $-0.16B | -1.69 |
| 2023-09-30 | $0.31B | $0.06B | 5.21 |
| 2023-06-30 | $0.30B | $0.07B | 4.37 |
| 2023-03-31 | $0.30B | $0.08B | 3.87 |
| 2022-12-31 | $0.30B | $0.09B | 3.23 |
| 2022-09-30 | $0.32B | $0.08B | 4.19 |
| 2022-06-30 | $0.32B | $0.09B | 3.62 |
| 2022-03-31 | $0.30B | $0.13B | 2.33 |
| 2021-12-31 | $0.30B | $0.15B | 2.01 |
| 2021-09-30 | $0.30B | $0.16B | 1.83 |
| 2021-06-30 | $0.30B | $0.19B | 1.58 |
| 2021-03-31 | $0.38B | $0.21B | 1.83 |
| 2020-12-31 | $0.40B | $0.24B | 1.66 |
| 2020-09-30 | $0.40B | $0.31B | 1.27 |
| 2020-06-30 | $0.44B | $0.29B | 1.50 |
| 2020-03-31 | $0.45B | $0.31B | 1.46 |
| 2019-12-31 | $0.49B | $0.31B | 1.57 |
| 2019-09-30 | $0.60B | $0.28B | 2.13 |
| 2019-06-30 | $0.65B | $0.55B | 1.20 |
| 2019-03-31 | $0.67B | $0.57B | 1.18 |
| 2018-12-31 | $0.69B | $0.61B | 1.12 |
| 2018-09-30 | $0.71B | $0.60B | 1.19 |
| 2018-06-30 | $0.64B | $0.61B | 1.06 |
| 2018-03-31 | $0.64B | $0.55B | 1.16 |
| 2017-12-31 | $0.68B | $0.52B | 1.30 |
| 2017-09-30 | $0.67B | $0.68B | 0.98 |
| 2017-06-30 | $0.64B | $0.69B | 0.93 |
| 2017-03-31 | $0.64B | $0.68B | 0.95 |
| 2016-12-31 | $0.68B | $0.66B | 1.02 |
| 2016-09-30 | $0.65B | $0.67B | 0.98 |
| 2016-06-30 | $0.67B | $0.68B | 0.98 |
| 2016-03-31 | $0.53B | $0.68B | 0.77 |
| 2015-12-31 | $0.51B | $0.60B | 0.84 |
| 2015-09-30 | $0.53B | $0.58B | 0.91 |
| 2015-06-30 | $0.54B | $0.56B | 0.96 |
| 2015-03-31 | $0.55B | $0.55B | 1.00 |
| 2014-12-31 | $0.53B | $0.54B | 0.97 |
| 2014-09-30 | $0.45B | $0.52B | 0.86 |
| 2014-06-30 | $0.44B | $0.50B | 0.89 |
| 2014-03-31 | $0.16B | $0.45B | 0.36 |
| 2013-12-31 | $0.17B | $0.44B | 0.38 |
| 2013-09-30 | $0.16B | $0.43B | 0.38 |
| 2013-06-30 | $0.17B | $0.41B | 0.42 |
| 2013-03-31 | $0.17B | $0.39B | 0.44 |
| 2012-12-31 | $0.18B | $0.39B | 0.47 |
| 2012-09-30 | $0.17B | $0.25B | 0.67 |
| 2012-06-30 | $0.17B | $0.23B | 0.76 |
| 2012-03-31 | $0.17B | $0.22B | 0.76 |
| 2011-12-31 | $0.17B | $0.21B | 0.85 |
| 2011-09-30 | $0.16B | $0.19B | 0.88 |
| 2011-06-30 | $0.17B | $0.16B | 1.07 |
| 2011-03-31 | $0.18B | $0.16B | 1.17 |
| 2010-12-31 | $0.19B | $0.15B | 1.26 |
| 2010-09-30 | $0.19B | $0.14B | 1.33 |
| 2010-06-30 | $0.17B | $0.12B | 1.41 |
| 2010-03-31 | $0.20B | $0.12B | 1.58 |
| 2009-12-31 | $0.18B | $0.14B | 1.33 |
| 2009-09-30 | $0.18B | $0.16B | 1.16 |
| 2009-06-30 | $0.20B | $0.17B | 1.14 |
| 2009-03-31 | $0.07B | $0.19B | 0.37 |
